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Abstract
Introduction Although a positive surgical margin is a known prognostic factor for recurrence, the optimal surgical margin width
in the context of an R0 resection for early-stage hepatocellular carcinoma (HCC) is still debated. The aim of the current study was
to examine the impact of wide (> 1 cm) versus narrow (< 1 cm) surgical margin status on the incidence and recurrence patterns
among patients with T1 HCC undergoing an R0 hepatectomy.
Methods Between 1998 and 2017, patients with T1 HCC who underwent R0 hepatectomy for stage T1 HCC were identified
using an international multi-institutional database. Recurrence-free survival (RFS) was estimated, and recurrence patterns were
examined based on whether patients had a wide versus narrow resection margins.
Results Among 404 patients, median patient age was 66 years (IQR: 58–73). Most patients (n = 326, 80.7%) had surgical margin <
1 cm, while 78 (19.3%) patients had a > 1 cm margin. The majority of patients had early recurrences (< 24 months) in both margin
width groups (< 1 cm: 70.3% vs > 1 cm: 85.7%, p = 0.141); recurrence site was mostly intrahepatic (< 1 cm: 77% vs > 1 cm: 61.9%,
p = 0.169). The 1-, 3-, and 5-year RFS among patients with margin < 1 cm were 77%, 48.9%, and 35.3% versus 81.7%, 65.8%, and
60.7% for patients with margin > 1 cm, respectively (p= 0.02). Among patients undergoing anatomic resection, resection margin did
not impact RFS (3-year RFS: < 1 cm: 49.2% vs > 1 cm: 58.9%, p = 0.169), whereas in the non-anatomic resection group, marginwidth
> 1 cm was associated with a better 3-year RFS compared to margin < 1 cm (86.7% vs 47.3%, p = 0.017). On multivariable analysis,
margin > 1 cm remained protective against recurrence (HR= 0.50, 95%CI 0.28–0.89), whereas Child-Pugh B (HR= 2.13, 95%CI
1.09–4.15), AFP > 20 ng/mL (HR= 1.71, 95%CI 1.18–2.48), and presence of microscopic lymphovascular invasion (HR= 1.48,
95%CI 1.01–2.18) were associated with a higher hazard of recurrence.
Conclusion Resection margins > 1 cm predicted better RFS among patients undergoing R0 hepatectomy for T1 HCC, especially
small (< 5 cm) HCC. Although resection margin width did not influence outcomes after anatomic resection, wider margins were
more important among patients undergoing non-anatomic liver resections.
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Introduction
Hepatocellular carcinoma (HCC) ranks as one of the
most prevalent malignancies worldwide with an increas-
ing incidence over the last few decades.1, 2 Surgery, in
the form of either liver resection or transplantation, re-
mains the mainstay of treatment for patients with resect-
able HCC.3, 4 Despite the advances in surgical tech-
niques, cumulative recurrence rates are still high,
reaching up to 70–80% among patients undergoing resec-
tion for HCC.5 Recurrence is clearly multifactorial, yet
the surgical margin is considered the traditional corner-
stone of resection. Although a positive margin status has
been associated with lower recurrence rates,4, 5 the opti-
mal surgical margin width in the context of R0 resection
is still debated. For example, a few studies have reported
that a resection margin smaller than 1 cm was an adverse
prognostic factor for recurrence.6–8 Other investigators
have argued that a 0.5- to 1-cm surgical margin does
not increase the risk for recurrence and should be con-
sidered an adequate margin for resection of small-size
tumors (< 5 cm).9 In contrast, a recent meta-analysis not-
ed that a wide surgical margin (> 1 cm) was associated
with an improved prognosis among patients undergoing
resection for HCC compared with a narrow margin (<
1 cm).10 As such, no current consensus exists regarding
the optimal margin width for curative-intent hepatectomy.
In addition, patterns of HCC recurrence relative to
surgical margin width are also poorly understood. Of
note, intrahepatic metastases usually occur early after
surgery, whereas multicentric occurrence is usually ob-
served after a longer amount of time following
hepatectomy.11 The effect of margin width on recurrence
patterns has not been examined to date, with only one
small study suggesting that patterns of recurrence (i.e.,
intra- or extrahepatic, early or late recurrence) may not
be influenced by the extent of surgery.12 Nevertheless,
narrow margins have been suggested to increase the risk
of leaving Bmicro-metastases^ given that HCC may track
along the portal triad. The objective of the current study
was to determine the effect of surgical margin width on
recurrence after resection for HCC. Specifically, we
sought to examine whether a narrow (< 1 cm) versus a
wide (> 1 cm) surgical margin impacted the incidence of
recurrence, as well as define patterns of recurrence. In
addition, clinical and pathological factors associated with
recurrence following R0 hepatectomy for solitary tumors
without macrovascular invasion were identified.
Materials and Methods
Study Population and Data Collection
Patients who underwent curative-intent R0 hepatectomy for
histologically proven T1 HCC (solitary HCC without macro-
scopic vascular invasion) between 1998 and 2017 were iden-
tified using an international multi-institutional database.
Patients were treated at 1 of 11 following participating insti-
tutions: the Ohio State University Wexner Medical Center,
Columbus, OH, USA; Yokohama City University School of
Medicine, Yokohama, Japan; University of Verona, Verona,
Italy; Ospedale San Raffaele, Milano, Italy; Curry Cabral
Hospital, Lisbon, Portugal; APHP, Beaujon Hospital, Clichy,
France; Westmead Hospital, Sydney, Australia; Stanford
University, Stanford, CA, USA; Fundeni Clinical Institute,
Bucharest, Romania; University of Ottawa, Ottawa, Canada;
The University of Sydney, School of Medicine, Sydney,
Australia. Data on surgical margin width were collected based
on pathological examination of the resected HCC. Patients
were followed and outcomes were recorded in a prospectively
maintained multi-institutional database. Patients who had R1/
R2 hepatectomy, multiple tumors, and/or macroscopic vascu-
lar invasion were excluded from this analysis. The study was
approved by the Institutional Review Boards of all participat-
ing institutions.
Variables and Outcomes of Interest
The primary outcome was recurrence-free survival (RFS);
RFS was defined as the time interval between the date of
hepatectomy and the date of disease relapse or last follow-
up. The secondary outcome was overall survival (OS); OS
was defined as the time interval between the date of hepatec-
tomy and the date of death or last follow-up. The primary
independent variable was surgical margin width identified af-
ter pathological examination of the resected tumor.
Demographic and clinical data included age, sex, race,
Charlson comorbidity score (CCS), history of cirrhosis, hep-
atitis B virus (HBV)/hepatitis C virus (HCV) infection, Child-
Pugh liver function, grade type of surgical resection (i.e., an-
atomic or non-anatomic), laboratory values (i.e., a-fetoprotein
(AFP), alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), gamma-glutamyl transferase (GGT)), tumor
grade, tumor size, pathologic lymphovascular invasion, and
liver capsule involvement. In addition, patterns of recurrence,
such as recurrence site (intrahepatic, extrahepatic), type
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(single, multiple), size, and early recurrence were examined.
Local recurrence was defined as relapse in the nearest surgical
margin; early recurrence was defined as disease relapse within
24 months after hepatectomy.
Statistical Analysis
Descriptive statistics were presented as median (interquartile
range [IQR]) and frequency (%) for continuous and categori-
cal variables, respectively. Bivariate analyses included
Wilcoxon rank-sum test for continuous and chi-squared test
or Fisher’s exact test for categorical variables, as appropriate.
Bivariate survival analyses were performed using the log-rank
test and presented using Kaplan-Meier curves. Variables sig-
nificant on bivariate analysis (p value < 0.05) were entered
into the multivariable model. Multivariable survival analyses
were performed using Cox proportional hazards regression
analysis. The level of statistical significance was set at α =
0.05. All analyses were performed using SPSS, version 25
(IBM Corp., Armonk, NY, USA).
Results
Patient Characteristics
Between 1998 and 2017, a total of 404 patients met the inclu-
sion criteria and were included in the analytic cohort (Fig. 1).
Overall, median patient age was 66 years (IQR: 58–73), and
most patients were male (n = 299, 74.2%), white (n = 185,
59.1%), and had a median Charlson comorbidity score of 5
(IQR 4–6). History of cirrhosis and chronic alcoholism was
prevalent in 36.7% (n = 148) and 23.7% (n = 94) of patients,
respectively. Roughly one-fourth and one-third of patients had
a history of HBV (n = 93, 23%) or HCV infection (n = 117,
29%), respectively. Median HCC size was 4.3 cm (IQR: 3–8).
The majority of patients were Child-Pugh A (n = 274, 94.5%),
had well/moderately differentiated tumors (n = 316, 81.5%),
and had undergone anatomic resection for HCC (n = 320,
79.2%). On histological examination, 31.8% (n = 118/371)
of patients had lymphovascular invasion, whereas liver cap-
sule involvement was present in 31.4% (n = 88/280) of the
patients (Table 1).
Of the 404 patients, 326 (80.7%) patients had a surgical
margin < 1 cm, while 78 (19.3%) patients had > 1 cm. At
baseline, the two groups were different only in terms of sex
and history of HCV infection; compared to margin group <
1 cm, margin group > 1 cm had fewer males (65.4% vs 76.3,
p = 0.048), and a lower incidence of HCV infection (16.7% vs
32%, p = 0.007). All other variables examined, including age,
race, CCS, cirrhosis, history of chronic alcoholism, HBV in-
fection, tumor size and grade, Child-Pugh class, type of resec-
tion, AFP, ALT, AST and GGT values, microscopic
lymphovascular invasion, and liver capsule involvement were
similar between the two groups (Table 1).
Recurrence Patterns
The median follow-up period was 28.5 months (IQR 11.6–
53.5 months). The recurrence patterns were similar between
Fig. 1 Flowchart of the selection
of patients included in the analytic
cohort
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Table 1 Patient and tumor
characteristics Variables Total
(n = 404)
< 1 cm (n = 326,
80.7%)




Age, years 66 (58, 73) 66 (58, 73) 65 (57, 73) 0.72
Gender 0.048
Female 104 (25.8%) 77 (23.7%) 27 (34.6%)
Male 299 (74.2%) 248 (76.3%) 51 (65.4%)
Race 0.512
White 185 (59.1%) 147 (58.1%) 38 (63.3%)
AA 34 (10.9%) 26 (10.3%) 8 (13.3%)
Other 94 (30%) 80 (31.6%) 14 (23.4%)
CCS 5 (4, 6) 5 (4, 6) 5 (4, 6) 0.57
Cirrhosis 0.926
No 255 (63.3%) 206 (63.4%) 49 (62.8%)
Yes 148 (36.7%) 119 (36.6%) 29 (37.2%)
Chronic alcoholism 0.10
No 302 (76.3%) 237 (74.5%) 65 (83.3%)
Yes 94 (23.7%) 81 (25.5%) 13 (16.7%)
HBV infection 0.4
No 306 (76.7%) 249 (77.6%) 57 (73.1%)
Yes 93 (23%) 72 (22.4%) 21 (26.9%)
HCV infection 0.007
No 286 (71%) 221 (68%) 65 (83.3%)
Yes 117 (29%) 104 (32%) 13 (16.7)
Tumor size, cm 4.3 (3, 8) 4 (3, 8) 4.5 (3, 8) 0.672
Tumor grade 0.504
Well 93 (24%) 74 (23.6%) 19 (18%)
Mod 223 (57.5%) 178 (56.9%) 45 (60%)
Poor 68 (17.5%) 57 (18.2%) 11 (14.7%)
Undif 4 (1%) 4 (1.3%) 0 (0%)
Child-Pugh class 0.516
A 274 (94.5%) 223 (94.9%) 51 (92.7%)
B 16 (5.5%) 12 (5.1%) 4 (7.3%)
Type of resection 0.58
AR 320 (79.2%) 260 (79.8%) 60 (76.9%)
NAR 84 (20.8%) 66 (20.2%) 18 (23.1%)
AFP, ng/mL 8 (3, 61) 8 (3, 97) 10 (3, 143) 0.79
ALT, U/L 41 (26, 68) 42 (26, 67) 39 (27, 75) 0.70
AST, U/L 41 (28, 61) 40 (28, 62) 43.5 (30, 62) 0.50
GGT, U/L 80 (48, 156) 79 (48, 155) 83 (42, 161) 0.76
Pathologic lymphovascular
invasion
253 (68.2%) 205 (69.5%) 48 (63.2%) 0.29
No 118 (31.8%) 90 (30.5%) 28 (36.8%)
Yes
Liver capsule involvement 0.14
No 192 (68.6%) 180 (69.8%) 12 (54.5%)
Yes 88 (31.4%) 78 (30.2%) 10 (45.5%)
AA African American, CCS Charlson Comorbidity Score, HBV hepatitis B virus, HCV hepatitis C virus, AR
anatomical resection, NAR non-anatomical resection, AFP a-fetoprotein, ALT alanine aminotransferase, AST
aspartate aminotransferase, GGT gamma-glutamyl transferase; Italics denote statistical significance
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the < 1 cm and > 1 cm margin groups (Table 2). The majority
of patients had early recurrence (< 24 months) in both groups
(< 1 cm: 70.3% vs > 1 cm: 85.7%, p = 0.141). The incidence
of local recurrence was 7.1% among patients with resection
margin < 1 cm versus 4.8% among patients with a margin >
1 cm (p = 1.0). When recurrence occurred, it was mostly
intrahepatic in both groups (< 1 cm: 77% vs > 1 cm: 61.9%,
p = 0.169). Recurrences in the resection margin < 1 cm group
involved single tumors (single 56.8%, multiple 43.2%), while
multiple tumor recurrences were slightly more common in
margin > 1 cm group (single 41.7%, multiple 58.3%) (p =
0.314). Size of the recurrent tumors was similar between the
two groups (margin < 1 cm; median tumor size: 2 cm, IQR
1.5–3.1 vs margin > 1 cm; 2.1 cm, IQR 1.2–3.6, p = 0.92).
Recurrence-Free and Overall Survival
Overall 1-, 3-, and 5-year RFS among patients with a surgical
margin < 1 cm were 77%, 48.9%, and 35.3% versus 81.7%,
65.8%, and 60.7% among patients with margin > 1 cm, re-
spectively (log-rank p = 0.02, Fig. 2). Similarly, 5-year OS
was worse among patients with a surgical margin < 1 cm ver-
sus patients with margin > 1 cm (60.2% vs 74%, p = 0.047).
Of note, when stratified by tumor size, patients with resection
margin > 1 cm had better RFS only among patients undergo-
ing resection for tumors < 5 cm (5-year RFS; < 1 cm: 39.6%
vs > 1 cm: 70.3%, log-rank p = 0.022); in contrast, among
patients with larger tumors (> 5 cm), no difference in RFS
was detected relative to surgical margin width (5-year RFS;
< 1 cm: 29.4% vs > 1 cm: 49.8%, log-rank p = 0.263).
Anatomic resection was performed among 79.8% (n = 260)
of patients who had a margin < 1 cm versus 76.9% (n = 60)
among patients with a margin > 1 cm (p = 0.58). After strati-
fying by extent of resection (i.e., anatomic, non-anatomic),
margin width (< 1 cm vs > 1 cm) did not impact RFS among
patients undergoing an anatomic resection for HCC (1-year
RFS 76.2% vs 80.2%, 2-year RFS: 58.9% vs 63.4%, 3-year
RFS 49.2% vs 58.9%; respectively, log-rank p = 0.169,
Supplemental Fig. 1a). In contrast, among patients with non-
anatomic resection, margin width > 1 cm was associated with
a better 3-year RFS compared with a margin width < 1 cm (3-
year RFS: 86.7% vs 47.3%, log-rank p = 0.017, Supplemental
Fig. 1b). Of note, pathologic lymphovascular invasion was
present in 30.5% (n = 90) versus 36.8% (n = 28) of patients
with a resection margin < 1 cm and > 1 cm, respectively (p =
0.29). Among patients with lymphovascular invasion, margin
status (< 1 cm vs > 1 cm) did not impact RFS (3-year RFS:
36% vs 48.1%, p = 0.42, Supplemental Fig. 2a); in contrast,
among patients without lymphovascular invasion, margin >
1 cmwas associated with better 3-year RFS (77.3% vs 54.7%,
p = 0.017, Supplemental Fig. 2b).
On multivariable analysis, after controlling for competing
risk factors, margin width > 1 cm remained protective against
recurrence (referent < 1 cm: HR = 0.50, 95%CI 0.28–0.89,
p = 0.017) (Table 3). In contrast, Child-Pugh B (referent A:
HR = 2.13, 95%CI 1.09–4.15, p = 0.027), AFP > 20 ng/mL
(referent < 20: HR = 1.71, 95%CI 1.18–2.48, p = 0.005),
ALT > 40 U/L (referent < 40: HR = 1.53, 95%CI 1.05–2.23,
p = 0.027), and microscopic lymphovascular invasion (HR =
1.48, 95%CI 1.01–2.18, p = 0.044) were associated with a
higher hazard of recurrence. Tumor size > 5 cm was also as-
sociated with increased risk of recurrence on bivariable anal-
ysis (referent < 5 cm: HR = 1.52, 95%CI 1.12–2.06, p =
0.007).
Discussion
Surgery remains the mainstay of treatment and the best chance
for cure among patients diagnosed with HCC.4 Nevertheless,
recurrence rates can be as high as 70% after curative-intent
hepatectomy.13 While R0 resection may improve long-term
Table 2 Recurrence patterns
stratified by surgical margin
width
Variables < 1 cm (n = 145, 44.5%) > 1 cm (n = 21, 26.9%) p value
Local recurrence 9 (7.1%) 1 (4.8%) 1.0
Recurrence site
Intrahepatic 97 (77%) 13 (61.9%) 0.169
Extrahepatic 18 (14.3%) 3 (14.3%)
Both 11 (8.7%) 5 (23.8%)
Recurrence type
Single 67 (56.8%) 5 (41.7%) 0.314
Multiple 51 (43.2%) 7 (58.3%)
Recurrence size, cm 2 (1.5, 3.1) 2.1 (1.2, 3.6) 0.92
Time to recurrence, months
< 24 102 (70.3%) 18 (85.7%) 0.141
> 24 43 (29.7%) 3 (14.3%)
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outcomes, the extent of surgical margin width that may be
associated with the best outcomes following surgical treat-
ment remains a subject of debate.8, 9, 14 Narrowmargins could
potentially increase the chances of recurrence as Bmicro-
metastases^ may be present in the tumor periphery.15 On the
other hand, preserving the maximum possible liver parenchy-
ma after resection is of paramount importance for patient re-
covery and overall survival.15, 16 The current study was im-
portant because we specifically examined the effect of resec-
tion margin on the incidence of recurrence, as well as patterns
of recurrence, among patients undergoing R0 hepatectomy for
T1 HCC utilizing an international multi-institutional database.
Of note, wide-resectionmargins (> 1 cm) were associatedwith
better RFS compared with narrow margins (< 1 cm). This
effect was more pronounced among patients undergoing re-
section for small (< 5 cm) HCC. Also, recurrences in both
groups were largely intrahepatic and most often occurred
within 24months following R0 hepatectomy. Perhaps of more
interest, there were differences in the effect of margin width
based on the type of resection (i.e., anatomic, non-anatomic)
and the presence of pathologic lymphovascular invasion. In
particular, among patients undergoing anatomic resection,
wide-resection margin was not associated with RFS, whereas
among patients who underwent a non-anatomic resection,
wider margins were associated with a lower recurrence risk. In
addition, wide surgical margins were associated with lower recur-
rence when microscopic lymphovascular invasion was absent; in
contrast, RFS was worse overall in the presence of
lymphovascular invasion and therewas no effect ofmarginwidth.
Several studies have previously examined the relationship
between resection margin and the recurrence.8, 9, 14 In one
study from Taiwan, Lee et al. compared long-term outcomes
of patients stratified by margin width (i.e., 1–5, 6–10 and >
10 mm).14 The authors noted no difference in 1-, 3-, and 5-
year RFS (p = 0.354) and OS (p = 0.073) stratified by different
margin widths; however, patients in the wide margin group
experienced more postoperative complications (p = 0.020).14
Other studies have also demonstrated that a 0.5- to 1-cm sur-
gical margin width did not increase the risk for recurrence and
suggested that this was acceptable for the resection of small-
size tumors (< 5 cm).9 In a more rigorous prospective random-
ized trial, Shi et al. reported that a resection margin that aimed
a gross margin width of 2 cm decreased recurrence rates and
increased OS compared with a gross resection margin of
1 cm.8 Interestingly, this difference was more pronounced
among patients who had anHCC < 2 cm.8 In the current study,
we used an international multi-institutional database to exam-
ine patients with early T1 HCC. We noted that a resection
margin > 1 cm was associated with a better RFS versus a <
1-cm margin (5-year RFS: 60.7% vs 35.3%, p = 0.02); the
difference in RFS based on margin width persisted on multi-
variable analysis after controlling for competing risk factors
(HR = 0.50, 95%CI 0.28–0.89). Importantly, the effect of re-
section margin was more pronounced among patients under-
going resection for small (< 5 cm) HCC, whereas for larger
tumors (> 5 cm), the difference in RFS did not reach statistical
significance. Whereas most previous studies suffered from
heterogeneity and variations in the selection of patients,8 the
Fig. 2 Kaplan-Meier curve
demonstrating the differences in
recurrence-free survival among
patients with < 1 cm and > 1 cm
resection margin
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two margin width groups in the current study were similar
with regard to baseline characteristics except for sex and his-
tory of HCV infection. Consistent with our findings, a recent
meta-analysis also noted an improved OS and RFS among
patients undergoing hepatectomy who had wide (> 1 cm) ver-
sus narrow surgical margins (< 1 cm).10 Collectively, these
data strongly suggest that a wide surgical margin may be as-
sociated with improved outcomes for patients undergoing
hepatectomy for T1 HCC, especially for small (< 5 cm) HCC.
The importance of surgical margins has been demonstrated
for other primary liver malignancies as well.15 For example, in
a multi-institutional analysis of 584 patients undergoing resec-
tion for intrahepatic cholangiocarcinoma, Spolverato et al. re-
ported that compared with a tumor-free margin > 1, a margin
of 5-9 mm, 1–4 mm, and positive margin were associated with
lower OS and RFS (p-trend < 0.001).17 Similarly, margin sta-
tus rather than extent of hepatectomy has been demonstrated
to influence outcomes among patients treated for gallbladder
cancer.18 Although a negative margin is undoubtedly recog-
nized as an adverse prognostic factor,6, 7, 19 the latest
European Association for the Study of the Liver (EASL)
HCC (2018)3 and the American Association for the Study of
Liver Diseases (2018)4 guidelines do not specifically refer to
the optimal margin width for patients undergoing hepatecto-
my for HCC in the context of a R0 resection. According to the
EASL HCC guidelines (2018), an anatomic resection should
be the preferred surgical approach provided that the patient
has an adequate future liver remnant.3 In the current study,
the percentage of patients undergoing anatomic resection
was similar between the two margin width groups (79.8% vs
76.9%, p = 0.58). However, anatomic resection did not predict
better outcomes relative to RFS (HR = 1.16, 95% CI 0.79–
1.70). Perhaps more interesting, surgical margin width did
not affect RFS in the context of an anatomic resection, sug-
gesting that a minimum resection margin was enough when
anatomic resection was performed. Indeed, for an anatomic
resection of liver, Glisson pipelines are ligated and cut off in
advance.20 In turn, more microvascular invasive lesions—
thought to be strongly correlated with disease relapse—can
theoretically be removed regardless of surgical margins when
liver parenchyma is dissected.20, 21 In contrast, a previous
report noted that, in the case of non-anatomic resections, a
wider surgical margin should be considered approapriate.19
Apart from the surgical margin, several other factors have
been identified as prognostic of recurrence. In particular, pres-
ence of microvascular invasion, cirrhosis, Child-Pugh B or C
class, need for transfusion, and HCC rupture 22–24 have been
demonstrated to increase risk of recurrence. The current study
confirmed these results as patients with Child-Pugh B liver
function were twice as likely to experience a recurrence
(HR = 2.13, p = 0.027), while patients with microscopic
lymphovascular invasion had almost 50% higher hazards of
recurrence (HR = 1.48, 1.01–2.18) compared with patients
Table 3 Bivariable and multivariable analysis of recurrence
Variable Bivariable Multivariable
HR (95%CI) p value HR (95%CI) p value
Margin group, cm
< 1 ref ref
> 1 0.58 (0.37–0.92) 0.021 0.50 (0.28–0.89) 0.017
Age, years
< 65 ref
> 65 1.01 (0.74–1.36) 0.988 – –
Gender
Female ref
Male 1.05 (0.74–1.49) 0.786 – –
Race
AA ref
White 0.79 (0.45–1.38) 0.403 – –
Other 0.78 (0.43–1.41) 0.42 – –
CCS
0–4 ref
5–9 1.10 (0.79–1.52) 0.57 – –
10–14 0.92 (0.37–2.30) 0.867 – –
Cirrhosis
No ref
Yes 1.02 (0.74–1.41) 0.88 – –
Chronic alcoholism
No ref
Yes 0.98 (0.68–1.40) 0.911 – –
HBV infection
No ref
Yes 1.04 (0.72–1.49) 0.842 – –
HCV infection
No ref
Yes 0.83 (0.60–1.16) 0.272 – –
Tumor size, cm
< 5 ref ref
> 5 1.52 (1.12–2.06) 0.007 1.27 (0.88–1.85) 0.20
Tumor grade
Well/Mod ref
Poor/Undif 1.21 (0.83–1.76) 0.31 – –
Child-Pugh class
A ref ref
B 2.36 (1.23–4.52) 0.01 2.13 (1.09–4.15) 0.027
Type of resection
NAR ref
AR 1.16 (0.79–1.70) 0.46 – –
AFP, ng/mL
< 20 ref ref
> 20 1.86 (1.34–2.60) < 0.001 1.71 (1.18–2.48) 0.005
ALT, U/L
< 40 ref ref
> 40 1.60 (1.14–2.25) 0.007 1.53 (1.05–2.23) 0.027
GGT, U/L
<64 ref
>64 1.44 (0.99–2.08) 0.052 – –
Pathologic lymphovascular invasion
No ref ref
Yes 1.82 (1.31–2.54) 0.001 1.48 (1.01-2.18) 0.044
Liver capsule involvement
No ref
Yes 0.72 (0.49–1.06) 0.098 – –
HR hazard ratio, CI confidence interval, AA African American, CCS
Charlson Comorbidity Score, HBV hepatitis B virus, HCV hepatitis C
virus, AR anatomical resection, NAR non-anatomical resection, AFP a-
fetoprotein, ALT alanine aminotransferase, AST aspartate aminotransfer-
ase, GGT gamma-glutamyl transferase Italics denote statistical
significance
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who did not have lymphovascular invasion. Indeed, impaired
liver function as determined by the Child-Pugh score has long
been considered a strong determinant of long-term outcomes
among patients undergoing liver resection for hepatobiliary
malignancies.22 In addition, although no specific AFP cut-
off level has been determined by the 8th AJCC stagingmanual
to be associated with recurrence, higher preoperative AFP
levels may indicate an aggressive tumor biology and, thus,
may predict worse outcomes.25 To this point, AFP levels >
20 ng/mL were associated with 1 higher hazards of recurrence
among patients undergoing resection for T1 HCC. To this end,
identifying patients at high risk of recurrencemay be crucial in
tailoring surveillance protocols or implementing adjuvant
therapies that could be of benefit to high-risk patients.26
Patterns of HCC recurrence, including multicentric occur-
rence, intrahepatic metastasis, or local recurrence, have not
been studied relative to surgical margin width. Of note, pat-
terns of recurrence among patients who underwent a resection
with wide versus narrow margins were similar (Table 2). In
particular, the majority of recurrences were intrahepatic in
both wide and narrow margin groups and most patients re-
curred in less than 24 months.12, 27 Intrahepatic metastases
likely occur early in the disease course, whereas multicentric
occurrence is usually observed after a certain amount of time
following hepatectomy for HCC.12, 27 Interestingly, approxi-
mately 60% of intrahepatic recurrences are thought to occur
close (< 2.5 cm) to the surgical margin.13 However, in the
current study, local recurrence at the surgical margins was
low in both groups (< 1 cm 7.1% vs > 1 cm 4.8%, p = 1.0).
Although early recurrence could not be predicted by the re-
section margin width, the evidence supports a strong correla-
tion between early recurrence and mesenchymal circulating
tumor cells, which could be used as potential biomarkers in
HCC monitoring following hepatectomy.28
Several limitations should be considered when interpreting
the current study. The retrospective nature of the analysis may
have introduced some selection biases. To limit patient selec-
tion bias, we restricted the analysis to only patients with T1
HCC such that the underlying clinicopathological characteris-
tics between the wide and narrow margin groups were similar.
As such, our results are applicable only to patients with T1
HCC. The number of patients in the non-anatomic group was
also limited and, thus, further studies will need to corroborate
the findings in this subset of patients. Data on neoadjuvant
chemotherapy were not available; yet, it is highly unlikely that
these patients received such treatment. In addition, the major-
ity of the patients were treated at major tertiary referral centers
and, therefore, the data may not be generalizable to the com-
munity setting.
In conclusion, wide resection margins (> 1 cm) were asso-
ciated with better RFS among patients undergoing R0 hepa-
tectomy for early T1 HCC, especially small (< 5 cm) HCC.
Certain factors, including Child-Pugh B liver function,
AFP > 20, and presence of microscopic lymphovascular inva-
sion can help identify patients at high risk for recurrence.
Irrespective of the margin width, most recurrences were
intrahepatic and occurred early after hepatectomy. Although
resection margins did not influence outcomes after anatomic
resection, wider margins were more important for patients
undergoing non-anatomic liver resections.
Compliance with Ethical Standards
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